| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
interferon alpha 1 | 0.371 | 0.923 |
|
disease | 0.400 | None | 0.857 | 20 | 0 | 1997 | 2018 | |||||||||
|
interferon alpha 13 | 0.374 | 0.923 |
|
disease | 0.100 | None | 0.850 | 20 | 0 | 1997 | 2018 | |||||||||
|
microRNA 122 | 0.468 | 0.808 |
|
disease | 0.100 | None | 1.000 | 11 | 0 | 2013 | 2019 | |||||||||
|
alcohol dehydrogenase 1C (class I), gamma polypeptide | 0.547 | 0.731 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 1991 | 2012 | |||||||||
|
microRNA 21 | 0.363 | 0.846 |
|
disease | 0.260 | None | 1.000 | 6 | 0 | 2014 | 2019 | |||||||||
|
inactive glutathione hydrolase 2 | 0.559 | 0.731 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 1995 | 2017 | |||||||||
|
H3 histone pseudogene 10 | 0.350 | 0.846 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2001 | 2018 | |||||||||
|
interferon alpha 2 | 0.442 | 0.885 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 1997 | 2014 | |||||||||
|
MT-CO2 pseudogene 12 | 0.368 | 0.962 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2012 | 2018 | |||||||||
|
microRNA 221 | 0.449 | 0.846 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2008 | 2017 | |||||||||
|
cytochrome c oxidase subunit II | 0.352 | 0.962 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2012 | 2018 | |||||||||
|
gamma-glutamyltransferase light chain 5 pseudogene | 0.513 | 0.846 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 2008 | 2020 | |||||||||
|
gamma-glutamyltransferase light chain family member 3 | 0.513 | 0.846 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 2008 | 2020 | |||||||||
|
gamma-glutamyltransferase light chain 4 pseudogene | 0.513 | 0.846 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 2008 | 2020 | |||||||||
|
TERT 5' regulatory region | 0.464 | 0.731 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2014 | 2019 | |||||||||
|
H3 histone pseudogene 23 | 0.443 | 0.769 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2005 | 2012 | |||||||||
|
Cbl proto-oncogene like 2 | 0.476 | 0.808 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2014 | 2018 | |||||||||
|
microRNA 146a | 0.398 | 0.885 |
|
disease | 0.030 | None | 1.000 | 3 | 1 | 2016 | 2019 | |||||||||
|
microRNA 155 | 0.384 | 0.885 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2016 | 2017 | |||||||||
|
microRNA 223 | 0.433 | 0.808 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2017 | 2019 | |||||||||
|
microRNA 224 | 0.534 | 0.654 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2015 | 2019 | |||||||||
|
telomerase RNA component | 0.471 | 0.846 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2011 | 2016 | |||||||||
|
long intergenic non-protein coding RNA 1672 | 0.462 | 0.846 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2018 | |||||||||
|
KLRC4-KLRK1 readthrough | 0.469 | 0.769 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2020 | |||||||||
|
tumor protein p53 pathway corepressor 1 | 0.628 | 0.500 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2015 | 2016 |